ArticleMedical oncology (Northwood, London, England)2026

Targeting STAT5A via CRISPR/Cas9 restores TKI sensitivity in resistant chronic myeloid leukemia cells.

Besne Çelik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.